WO2002000932A3 - Diagnose von bedeutenden genetischen parametern innerhalb des mhc - Google Patents

Diagnose von bedeutenden genetischen parametern innerhalb des mhc Download PDF

Info

Publication number
WO2002000932A3
WO2002000932A3 PCT/IB2001/001501 IB0101501W WO0200932A3 WO 2002000932 A3 WO2002000932 A3 WO 2002000932A3 IB 0101501 W IB0101501 W IB 0101501W WO 0200932 A3 WO0200932 A3 WO 0200932A3
Authority
WO
WIPO (PCT)
Prior art keywords
mhc
diagnosis
genetic parameters
known genetic
probes
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
PCT/IB2001/001501
Other languages
English (en)
French (fr)
Other versions
WO2002000932A2 (de
Inventor
Alexander Olek
Christian Piepenbrock
Kurt Berlin
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Epigenomics AG
Original Assignee
Epigenomics AG
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Epigenomics AG filed Critical Epigenomics AG
Priority to AU2001277653A priority Critical patent/AU2001277653A1/en
Priority to JP2002506246A priority patent/JP2004511217A/ja
Priority to EP01955494A priority patent/EP1358351A2/de
Publication of WO2002000932A2 publication Critical patent/WO2002000932A2/de
Anticipated expiration legal-status Critical
Publication of WO2002000932A3 publication Critical patent/WO2002000932A3/de
Ceased legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/82—Translation products from oncogenes
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • C07K14/4701—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals not used
    • C07K14/4702—Regulators; Modulating activity
    • C07K14/4703—Inhibitors; Suppressors
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6876—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
    • C12Q1/6883—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00—Oligonucleotides characterized by their use
    • C12Q2600/154—Methylation markers

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Genetics & Genomics (AREA)
  • Biophysics (AREA)
  • Biochemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Zoology (AREA)
  • Molecular Biology (AREA)
  • Medicinal Chemistry (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Engineering & Computer Science (AREA)
  • Analytical Chemistry (AREA)
  • Wood Science & Technology (AREA)
  • Microbiology (AREA)
  • Immunology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Engineering & Computer Science (AREA)
  • Biotechnology (AREA)
  • Toxicology (AREA)
  • Physics & Mathematics (AREA)
  • Pathology (AREA)
  • Oncology (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Other Investigation Or Analysis Of Materials By Electrical Means (AREA)

Abstract

Die vorliegende Erfindung beschreibt Nukleinsäuren zur Diagnose von einem Satz genetischer Parameter innerhalb des Major Histocompatibility Complexes (MHC), umfassend einen mindestens 20 Basenpaare langen revers komplementären oder identischen Abschnitt einer chemisch vorbehandelten genomischen DNA sowie einen Satz Oligomersonden (Oligonukleotide und/oder PNA-Oligomere), die zur Detektion des Cytosin-Metylierungszustandes in Nukleinsäuren dienen. Diese Sonden sind für die Diagnose von genetischen Parametern innerhalb des MHC besonders geeignet.
PCT/IB2001/001501 2000-06-30 2001-06-29 Diagnose von bedeutenden genetischen parametern innerhalb des mhc Ceased WO2002000932A2 (de)

Priority Applications (3)

Application Number Priority Date Filing Date Title
AU2001277653A AU2001277653A1 (en) 2000-06-30 2001-06-29 Diagnosis of known genetic parameters within the MHC
JP2002506246A JP2004511217A (ja) 2000-06-30 2001-06-29 組織適合性の大複合体内の遺伝的主要パラメーターによる診断
EP01955494A EP1358351A2 (de) 2000-06-30 2001-06-29 Diagnose von bedeutenden genetischen parametern innerhalb des mhc

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE10032529A DE10032529A1 (de) 2000-06-30 2000-06-30 Diagnose von bedeutenden genetischen Parametern innerhalb des Major Histocompatibility Complex (MHC)
DE10032529.7 2000-06-30

Publications (2)

Publication Number Publication Date
WO2002000932A2 WO2002000932A2 (de) 2002-01-03
WO2002000932A3 true WO2002000932A3 (de) 2003-09-04

Family

ID=7647778

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/IB2001/001501 Ceased WO2002000932A2 (de) 2000-06-30 2001-06-29 Diagnose von bedeutenden genetischen parametern innerhalb des mhc

Country Status (6)

Country Link
US (1) US20030186277A1 (de)
EP (1) EP1358351A2 (de)
JP (1) JP2004511217A (de)
AU (1) AU2001277653A1 (de)
DE (1) DE10032529A1 (de)
WO (1) WO2002000932A2 (de)

Families Citing this family (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7244822B2 (en) 2002-12-23 2007-07-17 Immunex Corporation BTL-II proteins
US20060183128A1 (en) * 2003-08-12 2006-08-17 Epigenomics Ag Methods and compositions for differentiating tissues for cell types using epigenetic markers
US7388127B2 (en) * 2004-02-24 2008-06-17 Korea Research Institute Of Bioscience And Biotechnology Multiple stress-inducible peroxidase promoter derived from Ipomoea batatas
US7932027B2 (en) 2005-02-16 2011-04-26 Epigenomics Ag Method for determining the methylation pattern of a polynucleic acid
EP1693468A1 (de) 2005-02-16 2006-08-23 Epigenomics AG Verfahren zur Bestimmung des Methylierungsmusters einer Polynukleinsäure
WO2006113770A1 (en) 2005-04-15 2006-10-26 Epigenomics Ag A method for providing dna fragments derived from a remote sample
WO2006111586A2 (es) * 2005-04-20 2006-10-26 Proyecto De Biomedicina Cima, S.L. Procedimiento para la determinación in vitro del grado de metilación del promotor de line-1
US8084734B2 (en) * 2006-05-26 2011-12-27 The George Washington University Laser desorption ionization and peptide sequencing on laser induced silicon microcolumn arrays
KR100862599B1 (ko) * 2007-08-13 2008-10-09 인제대학교 산학협력단 고구마 유래 식물 조직배양세포 고발현 프로모터 및 이를포함하는 식물 조직배양세포 고발현 벡터
WO2009108917A2 (en) * 2008-02-29 2009-09-03 Oncomethylome Sciences, S.A. Markers for improved detection of breast cancer
US8497066B2 (en) * 2008-12-04 2013-07-30 Rush University Medical Center DNA methylation based test for monitoring efficacy of treatment
US8110796B2 (en) 2009-01-17 2012-02-07 The George Washington University Nanophotonic production, modulation and switching of ions by silicon microcolumn arrays
US9490113B2 (en) * 2009-04-07 2016-11-08 The George Washington University Tailored nanopost arrays (NAPA) for laser desorption ionization in mass spectrometry
EP2825665B1 (de) * 2012-03-14 2017-09-06 Ruprecht-Karls-Universität Heidelberg Epigenetische signaturen als marker für kardiomyopathie und herzmuskelinsuffizienz
US9840742B2 (en) * 2014-06-16 2017-12-12 JBS Science Inc. Detection of hepatitis B virus (HBV) DNA and methylated HBV DNA in urine of patients with HBV-associated hepatocellular carcinoma
EP3314027A4 (de) 2015-06-29 2019-07-03 Caris Science, Inc. Therapeutische oligonukleotide
WO2023159138A2 (en) * 2022-02-17 2023-08-24 Northwestern University Use of dinucleotide repeat rnas to treat cancer

Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1999028498A2 (de) * 1997-11-27 1999-06-10 Epigenomics Gmbh Verfahren zur herstellung komplexer dna-methylierungs-fingerabdrücke

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2679252B1 (fr) * 1991-07-17 1993-12-10 Bio Merieux Systeme de sondes permettant d'effectuer le typage hla dr, et procede de typage utilisant lesdites sondes.
US5650277A (en) * 1992-07-02 1997-07-22 Diagenetics Ltd. Method of determining the presence and quantifying the number of di- and trinucleotide repeats
US5605798A (en) * 1993-01-07 1997-02-25 Sequenom, Inc. DNA diagnostic based on mass spectrometry
AU675333B2 (en) * 1993-06-11 1997-01-30 Commonwealth Scientific And Industrial Research Organisation Method for specific silencing of genes by DNA methylation
US5834183A (en) * 1993-06-29 1998-11-10 Regents Of The University Of Minnesota Gene sequence for spinocerebellar ataxia type 1 and method for diagnosis
US5939542A (en) * 1995-03-10 1999-08-17 Wakunaga Seiyaku Kabushiki Kaisha Detection of HLA-DR
US6025130A (en) * 1996-04-04 2000-02-15 Mercator Genetics, Inc. Hereditary hemochromatosis gene
DE19715430A1 (de) * 1997-04-14 1998-11-26 Boehringer Mannheim Gmbh Verfahren zur Typisierung von Allelen
JP2002521489A (ja) * 1998-07-27 2002-07-16 ユニバーシティ オブ アイオワ リサーチ ファウンデーション ＣｐＧオリゴヌクレオチドの立体異性体および関連する方法
DE19853398C1 (de) * 1998-11-19 2000-03-16 Epigenomics Gmbh Verfahren zur Identifikation von Cytosin-Methylierungsmustern in genomischer DNA
DE19905082C1 (de) * 1999-01-29 2000-05-18 Epigenomics Gmbh Verfahren zur Identifikation von Cytosin-Methylierungsmustern in genomischen DNA-Proben

Patent Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1999028498A2 (de) * 1997-11-27 1999-06-10 Epigenomics Gmbh Verfahren zur herstellung komplexer dna-methylierungs-fingerabdrücke

Non-Patent Citations (7)

* Cited by examiner, † Cited by third party
Title
CHENG N C ET AL: "Lack of class I HLA expression in neuroblastoma is associated with high N-myc expression and hypomethylation due to loss of the MEMO-1 locus.", ONCOGENE, vol. 13, no. 8, 1996, pages 1737 - 1744, XP009001932, ISSN: 0950-9232 *
DATABASE EMBL [online] 18 January 2000 (2000-01-18), XP002222758, retrieved from EMBL Database accession no. L76290 *
DATABASE EMBL [online] 29 January 1990 (1990-01-29), XP002222757, retrieved from EMBL Database accession no. X17093 *
FISZER DOROTA ET AL: "Major histocompatibility complex expression on human, male germ cells: A review.", AMERICAN JOURNAL OF REPRODUCTIVE IMMUNOLOGY, vol. 40, no. 3, 1998, pages 172 - 176, XP009001931, ISSN: 1046-7408 *
GRUEN JEFFREY R ET AL: "Evolving views of the major histocompatibility complex.", BLOOD, vol. 90, no. 11, 1 December 1997 (1997-12-01), pages 4252 - 4265, XP002222756, ISSN: 0006-4971 *
NIEMEYER C M ET AL: "DNA MICROARRAYS**", ANGEWANDTE CHEMIE, VCH VERLAGSGESELLSCHAFT, WEINHEIM, DE, vol. 38, no. 19, 1999, pages 3039 - 3043, XP000961724, ISSN: 0044-8249 *
REIN ET AL: "Identifying 5-methylcytosine and related modifications in DNA genomes", NUCLEIC ACIDS RESEARCH, OXFORD UNIVERSITY PRESS, SURREY, GB, vol. 26, no. 10, 1998, pages 2255 - 2264, XP002143106, ISSN: 0305-1048 *

Also Published As

Publication number Publication date
US20030186277A1 (en) 2003-10-02
DE10032529A1 (de) 2002-02-07
EP1358351A2 (de) 2003-11-05
WO2002000932A2 (de) 2002-01-03
AU2001277653A1 (en) 2002-01-08
JP2004511217A (ja) 2004-04-15

Similar Documents

Publication Publication Date Title
WO2002000932A3 (de) Diagnose von bedeutenden genetischen parametern innerhalb des mhc
WO2002018631A3 (de) Diagnose von bestehenden erkrankungen oder der prädisposition für bestimmte erkrankungen
WO2002000928A3 (de) Diagnose von mit dem immunsystem assoziierten krankheiten durch bestimmung der cytosin-methylierung
EP1002877A3 (de) Methode zur Genvervielfältigung
CA2278715A1 (en) Aminooxy-modified oligonucleotides
WO1997018334A3 (en) Nucleic acid probes complementary to human papillomavirus nucleic acid and related methods and kits
CA2190588A1 (en) Pteridine nucleotide analogs as fluorescent dna probes
HUP0003600A3 (en) Nucleic acid molecules from artichoke (cynara scolymus) encoding enzymes having fructosyl polymerase activity
DE69806003D1 (de) Dna polymerasen, die verbesserte fähigkeiten zum einbau markierter nukleotide besitzen
WO2001081622A8 (en) Diagnosis of diseases associated with dna repair
WO2002061133A3 (en) Nucleic acid detection using structured probes
WO1996006949A3 (en) Nucleic acid hybridization assay probes targeted to mycoplasma pneumoniae nucleic acid
WO2001047944A3 (en) Nucleic acids containing single nucleotide polymorphisms and methods of use thereof
WO2003014388A3 (en) Method and nucleic acids for the analysis of colon cancer
WO2002012554A3 (de) Diagnose von mit cd24 assoziierten krankheiten
WO2002006523A3 (en) Method for detecting pre-disposition to hepatotoxicity
CA2142156A1 (en) Nucleic Acid Sequences Specific for Mycobacterium Kansasii
WO2003002587A3 (en) Phosphoramide containing nucleic acid-based compounds and libraries as antivirals
WO2001029262A3 (en) Genotyping reagents, kits and methods of use thereof
DE69318072D1 (de) Genomische DNS-Fragmente von Streptococcus Pneumoniae, Hybridationssonden, Amplifikationsprimern und Verfahren für dessen Nachweis
AU9454201A (en) Oligonucleotide sequence formula for labeling oligonucleotide probe and proteinsfor in-situ analysis
AU2001254601A1 (en) Oligonucleotides or pna oligomers and a method for detecting the methylation state of genomic dna in a parallel manner
AU2002214041A1 (en) Diagnosis of diseases associated with the human c-mos gene
WO2001040521A3 (en) Nucleic acids containing single nucleotide polymorphisms and methods of use thereof
WO2001048245A3 (en) Nucleic acids containing single nucleotide polymorphisms and methods of use thereof

Legal Events

Date Code Title Description
AK Designated states

Kind code of ref document: A2

Designated state(s): AE AG AL AM AT AU AZ BA BB BG BR BY BZ CA CH CN CO CR CU CZ DE DK DM DZ EE ES FI GB GD GE GH GM HR HU ID IL IN IS JP KE KG KP KR KZ LC LK LR LS LT LU LV MA MD MG MK MN MW MX MZ NO NZ PL PT RO RU SD SE SG SI SK SL TJ TM TR TT TZ UA UG US UZ VN YU ZA ZW

AL Designated countries for regional patents

Kind code of ref document: A2

Designated state(s): GH GM KE LS MW MZ SD SL SZ TZ UG ZW AM AZ BY KG KZ MD RU TJ TM AT BE CH CY DE DK ES FI FR GB GR IE IT LU MC NL PT SE TR BF BJ CF CG CI CM GA GN GW ML MR NE SN TD TG

DFPE Request for preliminary examination filed prior to expiration of 19th month from priority date (pct application filed before 20040101)
121 Ep: the epo has been informed by wipo that ep was designated in this application
WWE Wipo information: entry into national phase

Ref document number: 2001955494

Country of ref document: EP

WWE Wipo information: entry into national phase

Ref document number: 2001277653

Country of ref document: AU

WWE Wipo information: entry into national phase

Ref document number: 10312841

Country of ref document: US

WWP Wipo information: published in national office

Ref document number: 2001955494

Country of ref document: EP

WWW Wipo information: withdrawn in national office

Ref document number: 2001955494

Country of ref document: EP